Use of phenol and botulinum toxin during a spasticity emergency

Authors

  • Gustavo Bocca-Peralta Médico Especialista en Medicina Física y Rehabilitación. Jefe del Servicio de Fisiatría, Hospital de Niños Dr. Roberto Gilbert E., Guayaquil, Ecuador https://orcid.org/0000-0003-0900-1782
  • Alfredo Iglesias-Bernal Médico Especialista en Medicina Física y Rehabilitación. Hospital de Niños Dr. Roberto Gilbert E, Guayaquil, Ecuador https://orcid.org/0000-0001-5722-3449
  • María Auxiliadora Jiménez-León Médico Especialista en Medicina Física y Rehabilitación. Hospital de Especialidades Teodoro Maldonado Carbo, Guayaquil, Ecuador

DOI:

https://doi.org/10.28957/rcmfr.v29n2a5

Keywords:

Muscle Spasticit, Botulinum Toxin, Urgent Care, Phenol

Abstract

Espasticity is a common symptom that impairs the quality of life, the activities of daily living and functionality in patients who suffers it. This case reports an 11-year-old female patient with spastic quadriplegia secondary to cerebral palsy. There was no improvement in the spasticity despite the use of baclofen and diazepam, which is why it required alternative treatment. Chemo denervation with botulinum toxin type A of 100U and neurolysis with phenol  at 5% was used. The main outcomes were the functional limitation, functional independence measure, the analogous visual scale, the Penn and Ashworth scale, which were measured before, immediately after, and 5 days after the procedure. Bilateral brachial biceps, erector spinae, bilateral rectus femoris and vastus lateralis were involved, which produced deformation of the joints and compromised the patient’s posture, in which 440U was applied divided according to the muscles. In addition, the musculocutaneous nerve was blocked. When the procedure was started, both subjective and objective results in spasticity were quickly observed, which suggests a potential role in the combination of these two drugs in spastic quadriplegia secondary to cerebral palsy.

References

1. Camacho-Salas A, Pallás-Alonso CR, de la Cruz-Bértolo J, Simón-de las Heras R, Mateos-Beato F. Parálisis cerebral: concepto y registros de base poblacional. Rev Neurol. 2007;45(8):503-8. Disponible en: https://doi.org/10.33588/rn.4508.2007309.

2. Póo P. Parálisis cerebral infantil. Protocolos Diagnóstico Terapeúticos de la Asociación Española de Pediatría AEP: Neurología Pediátrica. Barcelona: Hospital Sant Joan de Dèu; 2008.

3. Lance JW. The control of muscle tone, reflexes, and movement: Robert Wartenbeg Lecture. Neurology. 1980.30(12):1303-13. Disponible en: https://doi.org/10.1212/ wnl.30.12.1303.

4. Katoozian L, Tahan N, Zoghi M, Bakhsha- yesh B. The Onset and Frequency of Spasticity After First Ever Stroke. J Natl Med Assoc. 2018;110(6):547-52. Disponible en: https://doi.org/10.1016/j.jnma.2018.01.008.

5. Goetz C. Textbook of clinical neurology. 3rd ed. Philadelphia: Saunders Elsevier; 2007.

6. Silvariño R, Acevedo V, Moyano M, Méndez E, Paolillo E, Russi U, et al. Experiencia de triaje estructurado en el departamento de urgencia. Rev. Méd. Urug. 2011;27(2):88-93.

7. Sánchez-Perales F. Urgencia o atención in- mediata: una pequeña diferencia. Rev Pediatr Aten Primaria. 2009;11(44). Disponible en https://doi.org/10.4321/s1139-76322009000500001.

8. Anwar F, Ramanathan S. Combined Botulinum Toxin Injections and Phenol Nerve/Motor Point Blocks to Manage Multi- focal Spasticity in Adults. BJMP. 2017;10(1): a1002.

9. Gooch JL, Patton CP. Combining botulinum toxin and phenol to manage spasticity in children 1 1A commercial party with a direct financial interest in the results of the re- search supporting this article has conferred or will confer a financial benefit on the author or 1 or more of the authors. Archi- ves Of Physical Medicine And Rehabili- tation, 2004;85(7):1121-4. Disponible en: https://doi.org/10.1016/j.apmr.2003.09.032.

How to Cite

1.
Bocca-Peralta G, Iglesias-Bernal A, Jiménez-León MA. Use of phenol and botulinum toxin during a spasticity emergency. Rev. Colomb. Med. Fis. Rehabil. [Internet]. 2020 Apr. 2 [cited 2025 Oct. 18];29(2):107-10. Available from: https://revistacmfr.org/index.php/rcmfr/article/view/233

Downloads

Download data is not yet available.

Published

2020-04-02

Issue

Section

Clinical cases
Crossref Cited-by logo
QR Code
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views

Altmetric